Ozempic, Wegovy among new drugs selected for Medicare’s price negotiations
WASHINGTON — Popular weight-loss drugs Ozempic and Wegovy have been added to a list of Medicare drugs that will be negotiated directly between the government and drug manufacturers, the Biden administration said Friday. The incoming Trump administration will negotiate the prices of the additional 15 selected drugs, almost guaranteeing billions of dollars in savings for […]
Continue Reading